Director · Immunocore Holdings plc · Immunocore Holdings plc — Share Option (Right to Buy)
Side
A
Value
—
Shares
27.5K
Price
—
Executed
May 27, 2026
Disclosed
May 28, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
May 27 executedMay 28, 2026 disclosed
IMCR · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Immunocore Holdings plc — Share Option (Right to Buy)
Ticker
IMCR
Shares
27.5K
Price per share
$0
Execution date (reported)
May 27, 2026
Owned after transaction
27.5K shares
Days from execution to publication
1
What this establishes
Bell John Irving filed this Form 4 reporting a grant or award of IMCR on May 27, 2026. It became public on May 28, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Bell John Irvingcik:0001969932
Issuer
Immunocore Holdings plccik:0001671927
Revision history · 0
No field has changed since this record was first ingested.
